LDL (low-density lipoprotein) is primarily known for cholesterol transport and cardiovascular risk. Its direct role in allergies is not well established. Some evidence suggests that oxidized LDL can promote inflammatory processes that may also be involved in allergic reactions, such as activating macrophages or releasing cytokines. A few studies indicate possible interactions between LDL and the immune system, including allergen binding or modulation of antigen presentation. However, the evidence is mostly mechanistic and inconsistent. Genetic variants that affect LDL levels (e.g., in APOA5 or LDLR) are not directly linked to allergies. A DNA test for LDL-related SNPs (like rs3135506 in APOA5) does not predict allergy risk. Allergies are primarily driven by IgE-mediated responses, histamine, and specific allergen sensitization. LDL measurements in blood are used for cardiovascular risk assessment, not allergy diagnostics. In summary, LDL plays at most an indirect and unclear role in allergy pathogenesis. The available evidence is weak, based on cell or animal models, and does not support clinically relevant conclusions.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-505ee4a204191823c0894b20